Evofem Biosciences

+$0.008 (+2.31%) As of 3:51 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EVFM and other ETFs, options, and stocks.

About EVFM

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women.

CEO
Saundra L. Pelletier
Employees
119
Headquarters
San Diego, California
Founded
2007

EVFM Key Statistics

Market cap
4.51M
Price-Earnings ratio
—
Dividend yield
—
Average volume
4.21M
High today
$0.357
Low today
$0.3416
Open price
$0.35
Volume
1.08M
52 Week high
$21.30
52 Week low
$0.335

EVFM Earnings

-$8.40
-$5.60
-$2.80
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure